Hybrid particle immunogens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4722840
SERIAL NO

06777976

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel immunogenic compositions are provided involving viral particles composed at least in part of hybrid proteins of at least a portion of a particle forming protein and one or more polypeptides having at least one epitope of interest. Nucleic acid sequences are employed coding for the hybrid protein which are introduced into a host cell for expression, either by themselves or in combination with other DNA sequences coding for particle forming proteins. Expression of the DNA sequences results in formation of particles which may be isolated and used as immunogens for production of antibodies for diagnostics purposes, passive immunization, vaccination, or other uses. Saccharomyces carlsbergensis, 2150-2-3 (pDC103), was deposited on Sept. 7, 1984, at the ATCC and given ATCC Accession No. 20726. Also, Saccharomyces cerevisiae PO17 (pC1/1-MCS29) was deposited at the ATCC on Sept. 5, 1985, and given ATCC Accession No. 20770.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIRON CORPORATION A DE CORP4560 HORTON STREET EMERYVILLE CA 94608-2916

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barr, Philip J Orinda, CA 80 1320
Kuo, George San Francisco, CA 50 1383
Valenzuela, Pablo D T San Francisco, CA 28 1124

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation